FDA notified healthcare professionals and consumers that the Consumer Healthcare Products Association (CHPA) is voluntarily modifying the product labels for consumers of over the counter (OTC) cough and cold medicines to state "do not use" in children under 4 years of age.
FDA supports CHPA members to help prevent and reduce misuse and to better inform consumers about the safe and effective use of these products for children.
FDA continues to assess the safety and efficacy of these products and to revise its OTC list of approved ingredients and amounts for these medicines.
Parents and care givers should adhere to the dosage instructions and warnings on the label that accompanies OTC cough and cold medications before giving the product to children, and should consult their healthcare professionals if they have any questions or concerns.
Read the FDA statement: FDA News Release Oct 8, 2008
FDA supports CHPA members to help prevent and reduce misuse and to better inform consumers about the safe and effective use of these products for children.
FDA continues to assess the safety and efficacy of these products and to revise its OTC list of approved ingredients and amounts for these medicines.
Parents and care givers should adhere to the dosage instructions and warnings on the label that accompanies OTC cough and cold medications before giving the product to children, and should consult their healthcare professionals if they have any questions or concerns.
Read the FDA statement: FDA News Release Oct 8, 2008
